Japan Medical Dynamic Marketing, Inc. (JP:7600)
:7600
Want to see JP:7600 full AI Analyst Report?
7600 Stock Chart & Stats
¥487.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥487.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥461.00 - ¥758.00
Previous CloseN/A
Volume41.50K
Average Volume (3M)89.74K
Market Cap
¥15.33B
Enterprise Value¥16.30B
Total Cash (Recent Filing)¥2.35B
Total Debt (Recent Filing)¥4.31B
Price to Earnings (P/E)14.8
Beta0.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.12%
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,475,880
10 Day Avg. Volume96,020
30 Day Avg. Volume89,743
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.61
Price to Sales (P/S)0.60
P/FCF Ratio-29.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet / Low LeverageA strong equity base and conservative leverage give the company durable financial flexibility. This supports funding for product development, absorbs operational shocks and preserves borrowing capacity over the next 2-6 months without forcing dilutive financing.
Stable Gross MarginsRelatively stable gross margins indicate the company retains pricing power or cost control at the product level, which supports longer-term gross profitability even if operating expenses fluctuate, allowing focus on efficiency improvements and margin recovery.
Lower Earnings Volatility (low Beta)A low beta implies lower market volatility and can translate to steadier cash flow expectations and easier capital planning. This stability reduces refinancing and execution risk over a multi-month horizon, aiding strategic decisions and stakeholder confidence.
Bears Say
Profitability DeteriorationA shift to negative net margins signals core profitability issues that, if persistent, will erode retained earnings and restrict reinvestment. It raises concern about pricing, cost structure or product mix that could impair medium-term recovery plans.
Negative Free Cash FlowNegative free cash flow reduces internal funding for operations and growth and increases reliance on external financing. Over 2-6 months this heightens liquidity and execution risk, potentially forcing cost cuts or asset sales if cash conversion doesn't improve.
Recent Revenue And EPS DeclinesMaterial negative revenue and EPS growth point to weakening demand or execution failures. Such declines undermine scale economics and may pressure margins, R&D and capital allocation decisions, extending recovery time and increasing operational risk.
Japan Medical Dynamic Marketing, Inc. News
7600 FAQ
What was Japan Medical Dynamic Marketing, Inc.’s price range in the past 12 months?
Japan Medical Dynamic Marketing, Inc. lowest stock price was ¥461.00 and its highest was ¥758.00 in the past 12 months.
What is Japan Medical Dynamic Marketing, Inc.’s market cap?
Japan Medical Dynamic Marketing, Inc.’s market cap is ¥15.33B.
When is Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Japan Medical Dynamic Marketing, Inc.’s earnings last quarter?
Currently, no data Available
Is Japan Medical Dynamic Marketing, Inc. overvalued?
According to Wall Street analysts Japan Medical Dynamic Marketing, Inc.’s price is currently Overvalued.
Does Japan Medical Dynamic Marketing, Inc. pay dividends?
Japan Medical Dynamic Marketing, Inc. pays a Annually dividend of ¥15 which represents an annual dividend yield of 3.12%. See more information on Japan Medical Dynamic Marketing, Inc. dividends here
What is Japan Medical Dynamic Marketing, Inc.’s EPS estimate?
Japan Medical Dynamic Marketing, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Medical Dynamic Marketing, Inc. have?
Japan Medical Dynamic Marketing, Inc. has 26,475,880 shares outstanding.
What happened to Japan Medical Dynamic Marketing, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Japan Medical Dynamic Marketing, Inc.?
Currently, no hedge funds are holding shares in JP:7600
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.
Technical Analysis
CYBERDYNE
―
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Options Prices
Currently, No data available
---